J Ind Microbiol Biotechnol (2017) 44:1503–1510
1505
Purifcation of racemase from Ensifer sp. 23‑3
Analytical methods
and recombinant enzyme
Protein concentrations were measured using the Bio-Rad
protein assay kit (Bio-Rad Laboratories, Hercules, CA,
USA) with bovine serum albumin as a standard [5].
All purifcation procedures were performed at temperatures
below 4 °C. Wet cells (313 g) from 60 L of the culture were
suspended in 1.5 L of 20 mM KPB (pH 7.0) and disrupted
by Insonator 201 M (19 kHz; Kubota Corp., Tokyo, Japan)
for 20 min. After centrifugation (20,000×g, 30 min), the
supernatant was used as the cell-free extract.
SDS-PAGE was performed with an electrophoresis unit
(ATTO Corp., Tokyo, Japan). The molecular weight of an
enzyme subunit was estimated by SDS-PAGE on the basis of
relative mobility compared with those of standard proteins
(Bio-Rad Laboratories): phosphorylase b (97,400), bovine
serum albumin (66,200), ovalbumin (45,000), carbonic
anhydrase (31,000), trypsin inhibitor (21,500), and lysozyme
(14,400). The protein bands obtained in SDS-PAGE were
stained with Brilliant Blue G (Tokyo Chemical Industry
Co., Ltd.) and destained in MeOH/AcOH/water (3/1/6). The
molecular weight of the native enzyme was estimated by gel-
fltration HPLC using a Superdex 200 10/300 GL column
with 20 mM KPB (pH 7.0) containing 150 mM NaCl as the
eluent at 0.45 mL/min on the basis of relative mobility com-
pared with those of standard proteins (Oriental Yeast Co.,
Ltd., Tokyo, Japan): glutamate dehydrogenase (290,000),
lactate dehydrogenase (142,000), enolase (67,000), ade-
nylate kinase (32,000), and cytochrome C (12,400).
The cell-free extract was applied to a Q Sepharose (GE
Healthcare UK Ltd., Buckinghamshire, England) column
(300 mL), and the adsorbed enzyme was eluted with a
linear gradient of NaCl (0–300 mM) in 20 mM KPB (pH
7.0). The active fractions were brought to 30% (NH4)2SO4
saturation, and applied to a Butyl-Toyopearl 650 M (Tosoh
Corp., Tokyo, Japan) column (100 mL) equilibrated with
20 mM KPB (pH 7.0) containing 30% saturated (NH4)2SO4.
The adsorbed enzyme was eluted with a linear gradient of
(NH4)2SO4 (30–0% saturation) in 20 mM KPB (pH 7.0).
The active fractions were dialyzed against 20 mM KPB (pH
7.0) and applied to a DEAE-Toyopearl 650 M (Tosoh Corp.,
Tokyo, Japan) column (85 mL) equilibrated with 20 mM
KPB (pH 7.0). The adsorbed enzyme was eluted with a lin-
ear gradient of NaCl (0–500 mM) in 20 mM KPB (pH 7.0).
Then, the active fractions were applied to a Mono Q 10/100
GL (GE Healthcare UK Ltd.) column (8 mL), and eluted by
some conditions as DEAE-Toyopearl. The active fractions
were further applied to a Resource PHE (GE Healthcare
UK Ltd.) column (1 mL) and eluted by the same condi-
tions as Butyl-Toyopearl 650 M. The active fractions were
concentrated using Amicon Ultra-4 (Merck KGaA, Darm-
stadt, Germany), and applied to a Superdex 200 10/300 GL
(GE Healthcare UK Ltd.) column (24 mL) equilibrated with
20 mM KPB (pH 7.0).
Cloning, sequence analysis and expression of gene
encoding ACLR from Ensifer sp. 23‑3
Chromosomal DNA was isolated using a cell culture of
Ensifer sp. 23-3, and an overlapping region containing the
5′-teminal and 3′-terminal sequence of the ACLR gene (aclr)
was amplifed from the DNA of Ensifer sp. 23-3 using the
following primers, 5′-GGCGACAACGAGCCCTACAAC
ATCC-3′ and 5′-GATCGCGAAACGCTGGAGCCCGCG
-3′, which were based on alignments with other homologous
enzymes with an N-terminal amino acid sequence. The prod-
uct was purifed, cloned into the Novagen pT7 Blue T-vector
(Merck KGaA), and sequenced using an ABI PRISM 3500
genetic analyzer (Thermo Fisher Scientifc Inc., MA, USA).
The pET protein expression system, which is induced by
isopropyl-β-thiogalactopyranoside, was employed for the
overexpression of gene encoding ACLR from Ensifer sp.
23-3. The structural gene was amplifed from genomic DNA
by PCR using two primers, 5′-CGCGGCAGCCATATGGTG
ACCGAAGGCCTTTACGCCAGGG-3′ and 5′-CTCGAA
TTCGGATCCTCACCAGCCGGCGAATTCTGAAAGC-
3′, with Gfex DNA polymerase (Takara Bio Inc., Shiga,
Japan) for the construction of expression system. After the
digestion of pET28a by NdeI and BamHI, the amplifed gene
was ligated into pET28a using the In-Fusion HD cloning kit
(Takara Bio Inc.). The resulting construct (pET28a-aclr) was
introduced into E. coli BL21(DE3), and the recombinant
strain was cultured as described above.
The recombinant ACLR from the E. coli transformant
according to previously described procedures [17, 18]. The
cells were harvested by centrifugation at 8000 × g for 10 min
at 4 °C and washed with saline (0.85%). The cells were
resuspended in 20 mM KPB (pH 7.0), containing 250 mM
sucrose and 20 μM PLP, and disrupted by sonication for
10 min. The lysate was centrifuged at 8000×g for 10 min
at 4 °C, and the supernatant was purifed by nickel afnity
chromatography using His GraviTrap (GE Healthcare UK
Ltd.) according to the manual. The active fraction was used
for the characterization of recombinant ACLR.
Determination of N‑terminal amino acid sequence
For the determination of the N-terminal amino acid sequence
of racemase from Ensifer sp. 23-3, the active fraction was
analyzed using the Procise 494 HT protein sequence system
at APRO Life Science Institute Inc. (Tokushima, Japan).
1 3